罗玳红++黄琼++吕细华++徐银银++张爱民++李铮

[摘要]目的：观察火针治疗女性黄褐斑的临床有效性及安全性。方法：将60例气滞血瘀型女性黄褐斑患者随机分为治疗组和对照组，每组30例。治疗组：采用火针治疗，每周1次，连续治疗3个月；对照组：每日服用维生素C片和维生素E胶丸，配合晚间外涂复方氢醌霜治疗，连续治疗3个月。采用24项版本的汉密尔顿抑郁量表及《黄褐斑的临床诊断和疗效标准》中皮损积分量表对两组分别评价，比较治疗后两组的临床疗效。结果：两组治疗后抑郁症状积分及皮损积分与同组治疗前比较，差异均有统计学意义（P

[关键词]火针疗法；气滞血瘀型；黄褐斑；临床随机试验

[中图分类号]R758.4+2 [文献标志码]B [文章编号]1008-6455（2017）09-0099-03

Analysis on the Therapeutic Effect of Fire Needle on Qi Stagnation Type of Females Chloasma

LUO Dai-hong， HUANG Qiong， LV Xi-hua， XU Yin-yin， ZHANG Ai-min， LI Zheng

（Department of Acupuncture and Rehabilitation ，Longgang Hospital of Traditional Chinese Medicine， Shenzhen 518000，Guangdong，China）

Abstract： Objective Observations on the therapeutic effect of fire needle on qi stagnation type of feminines chloasma. Methods Sixty patients with qi Stagnation type of feminine were randomly allocated to treatment and control groups，30 cases each.The treatment group received Fire Needle， Once weekly and three months of continuous treatment.The control group oral tablets of Vitamin C and Vitamin E capsules everyday and three months of continuous treatment. The symptoms of chronic fatigue syndrome were scored byusing the Hamilton Depression Scale（HAMD） andclinical diagnosis and efficacy standards of Chloasma after treatment.The clinical therapeutic effects were compared between the two groups. Results There was a statistically significant pre-/post-treatment difference in the clinical symptom score in both groups （P<0.01）.There was a statistically significant difference in the pre-/post-treatment clinical symptom score difference value between the treatment and control groups （P

Key words： fire needle； qi stagnation type； chloasma； clinical randomized trial

黄褐斑是临床常见的一种获得性色素增加性皮肤病，好发于面颊部，常呈左右对称、蝶形分布，其次是在前额、鼻部[1-2]，多见于中青年已婚已育女性，除了影响容貌外，还会为女性带来焦虑和不悦，影响日常生活。不良生活习惯、遗传因素、紫外线照射、妊娠、焦虑抑郁、口服避孕药或抗癫痫药物等都可能是黄褐斑发生的原因[3]。2014年2月-2015年2月，笔者选择气滞血瘀型女性黄褐斑患者60例，采用火针治疗，并与内服维生索C片及维生索E膠丸配合外涂复方氢醌霜治疗进行疗效比较，现将结果报道如下。

1 临床资料

1.1 一般资料：60例气滞血瘀型黄褐斑均为就诊于香港药师堂诊所、广州医科大学卫生职业技术学院医务室的患者，根据就诊先后顺序，按随机数字表将患者分为治疗组和对照组，每组30例，均为女性，年龄23～57岁，病程4个月～17年。……